BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 29305964)

  • 1. In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity.
    Gatti M; Solari A; Pattarozzi A; Campanella C; Thellung S; Maniscalco L; De Maria R; Würth R; Corsaro A; Bajetto A; Ratto A; Ferrari A; Daga A; Barbieri F; Florio T
    Exp Cell Res; 2018 Feb; 363(1):48-64. PubMed ID: 29305964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
    Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
    BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of the metabolic modulator Metformin on osteosarcoma cancer stem-like cells.
    Paiva-Oliveira DI; Martins-Neves SR; Abrunhosa AJ; Fontes-Ribeiro C; Gomes CMF
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):49-63. PubMed ID: 29086064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro.
    Chen X; Hu C; Zhang W; Shen Y; Wang J; Hu F; Yu P
    Tumour Biol; 2015 Dec; 36(12):9873-83. PubMed ID: 26164004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin Suppresses Self-Renewal Ability and Tumorigenicity of Osteosarcoma Stem Cells via Reactive Oxygen Species-Mediated Apoptosis and Autophagy.
    Zhao B; Luo J; Wang Y; Zhou L; Che J; Wang F; Peng S; Zhang G; Shang P
    Oxid Med Cell Longev; 2019; 2019():9290728. PubMed ID: 31827709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
    Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
    J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canine osteosarcoma cell lines contain stem-like cancer cells: biological and pharmacological characterization.
    Gatti M; Wurth R; Vito G; Pattarozzi A; Campanella C; Thellung S; Maniscalco L; De Maria R; Villa V; Corsaro A; Nizzari M; Bajetto A; Ratto A; Ferrari A; Barbieri F; Florio T
    Jpn J Vet Res; 2016 May; 64(2):101-12. PubMed ID: 27506084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft.
    Martins-Neves SR; Paiva-Oliveira DI; Fontes-Ribeiro C; Bovée JVMG; Cleton-Jansen AM; Gomes CMF
    Cancer Lett; 2018 Feb; 414():1-15. PubMed ID: 29126913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin targets gastric cancer stem cells.
    Courtois S; Durán RV; Giraud J; Sifré E; Izotte J; Mégraud F; Lehours P; Varon C; Bessède E
    Eur J Cancer; 2017 Oct; 84():193-201. PubMed ID: 28822889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line.
    Martins-Neves SR; Lopes ÁO; do Carmo A; Paiva AA; Simões PC; Abrunhosa AJ; Gomes CM
    BMC Cancer; 2012 Apr; 12():139. PubMed ID: 22475227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin increases sensitivity of osteosarcoma stem cells to cisplatin by inhibiting expression of PKM2.
    Shang D; Wu J; Guo L; Xu Y; Liu L; Lu J
    Int J Oncol; 2017 May; 50(5):1848-1856. PubMed ID: 28393220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorigenicity.
    Yi XJ; Zhao YH; Qiao LX; Jin CL; Tian J; Li QS
    Mol Med Rep; 2015 Oct; 12(4):5042-8. PubMed ID: 26134785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant targeting of multiple key transcription factors effectively disrupts cancer stem cells enriched in side population of human pancreatic cancer cells.
    Wang X; Liu Q; Hou B; Zhang W; Yan M; Jia H; Li H; Yan D; Zheng F; Ding W; Yi C; Hai Wang
    PLoS One; 2013; 8(9):e73942. PubMed ID: 24040121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global gene expression analysis of canine osteosarcoma stem cells reveals a novel role for COX-2 in tumour initiation.
    Pang LY; Gatenby EL; Kamida A; Whitelaw BA; Hupp TR; Argyle DJ
    PLoS One; 2014; 9(1):e83144. PubMed ID: 24416158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.
    Petrachi T; Romagnani A; Albini A; Longo C; Argenziano G; Grisendi G; Dominici M; Ciarrocchi A; Dallaglio K
    Oncotarget; 2017 Jan; 8(4):6914-6928. PubMed ID: 28036292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitizing osteosarcoma stem cells to doxorubicin-induced apoptosis through retention of doxorubicin and modulation of apoptotic-related proteins.
    Gonçalves C; Martins-Neves SR; Paiva-Oliveira D; Oliveira VE; Fontes-Ribeiro C; Gomes CM
    Life Sci; 2015 Jun; 130():47-56. PubMed ID: 25818183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells.
    Bao B; Wang Z; Ali S; Ahmad A; Azmi AS; Sarkar SH; Banerjee S; Kong D; Li Y; Thakur S; Sarkar FH
    Cancer Prev Res (Phila); 2012 Mar; 5(3):355-64. PubMed ID: 22086681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity.
    Gatti M; Pattarozzi A; Bajetto A; Würth R; Daga A; Fiaschi P; Zona G; Florio T; Barbieri F
    Toxicology; 2013 Dec; 314(2-3):209-20. PubMed ID: 24157575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin reduces SATB2-mediated osteosarcoma stem cell-like phenotype and tumor growth via inhibition of N-cadherin/NF-kB signaling.
    Xu HY; Fang W; Huang ZW; Lu JC; Wang YQ; Tang QL; Song GH; Kang Y; Zhu XJ; Zou CY; Yang HL; Shen JN; Wang J
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4516-4528. PubMed ID: 29131265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
    Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
    Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.